Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.0800 (4.39%) ($26.7400 - $28.3300) on Thu. Nov. 15, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.64% (three month average) | RSI | 59 | Latest Price | $28.0800(4.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(60%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.82% in a week (0% probabilities). VXX(-13%) VIXM(-11%) TLT(-5%) GDXJ(-5%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.82% (StdDev 3.64%) | Hourly BBV | 0 () | Intraday Trend | 4.6% | | | |
|
5 Day Moving Average | $28.22(-0.5%) | 10 Day Moving Average | $28.26(-0.64%) | 20 Day Moving Average | $27.2(3.24%) | To recent high | -15.4% | To recent low | 15.1% | Market Cap | $1.744b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |